IndiaInfoline » Markets » CAPLIPOINT

Caplin Point Laboratories Ltd - Share Price

CAPLIPOINT

Open

507.00

Prev. Close

514.20

Turnover (lac.)

449

Day's High

514.70

Day's Low

500.00

52 Week's High

686.00

52 Week's Low

176.20

Book Value

85

Face Value

2

Mkt Cap (Cr.)

3,849

P/E

21.43

EPS

23.73

Divi. Yield

0.49

Caplin Point Laboratories LtdFinancials

Switch to
Consolidated
Standalone

Loading ...

Caplin Point Laboratories LtdNews & Updates

Peer Comparison

No Records found

Name LTP PE Mar Cap NP Qtr Div. Yld Sales Qtr BV

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.

Caplin Point Laboratories LtdSummary & Reports

Incorporated in the year 16th April, 1990 Caplin Point Laboratories was promoted by P C Partheeban, T Palanisamy, S Karunakaran, S Jayaraman and B A Ahmed. The company manufactures pharmaceutical formulations in the form of tablets, ointments and capsules, liquid orals and oral powders. As on 31 March 2019, the Company has four subsidiaries, viz Caplin Steriles Limited, Argus Salud Pharma LLP, Caplin Point Far East Limited - Hongkong a... More

Registered Office

Ashvich Towers 3rd Floor,No 31 Developed Plots Ind Est,Chennai, Tamil Nadu,600096

Tell. : +
Website : http://www.caplinpoint.net
Email : info@caplinpoint.net

Registrar Office

2nd Floor Kences Tow, Usman Road T.Nagar, Chennai-600017 INDIA

Tell. : +91-44-28140801/803
Website : www.integratedindia.in
Email : sureshbabu@iepindia.com/yesbalu@iepindia.com

Latest Release by caplin-point-laboratories-ltd

View

- <

Reco. Price

Oct 29,2020 02:50 PM

Target Price

Target Returns:

0.00%

Result Express

Caplin Point Laboratories Ltd's Q2FY19 consolidated net profit rises 22.4% yoy to Rs43.50cr : Misses Estimates

Oct 30, 2020 08:13 AM

The company’s consolidated revenue stood at Rs155.86cr, up 18.7% yoy and 6.42% qoq.

Shareholding Snapshot

Loading ...

Corporate Action

  • Purpose

    AGM

    Exp. Date

    28 Sep 2020

    Annc. Date

    10 Aug 2020

    Caplin Point Laboratories Ltd has informed BSE about Outcome of Board Meeting held on August 10, 202... More

  • Purpose

    Dividend

    Annc. Date

    18 Jun 2020

    Effective. Date

    21 Sep 2020

    Divi. Type

    Final

    Divi.(%)

    20

    Divi. Amt.

    0.4

    Caplin Point Laboratories Ltd has informed BSE that the Board of Directors of the Company at its mee... More

  • Purpose

    Board Meeting

    Exp. Date

    10 Aug 2020

    Annc. Date

    03 Aug 2020

    CAPLIN POINT LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Com... More